Back
Marinus Pharmaceuticals 10K Form
Sell
33
MRNS
Marinus Pharmaceuticals
Last Price:
0.35
Seasonality Move:
14.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | MRNS/Marinus Pharmaceuticals Quarterly |
| 2023-11-07 | 10Q | MRNS/Marinus Pharmaceuticals Quarterly |
| 2023-08-10 | 10Q | MRNS/Marinus Pharmaceuticals Quarterly |
| 2023-05-11 | 10Q | MRNS/Marinus Pharmaceuticals Quarterly |
| 2022-11-07 | 10Q | MRNS/Marinus Pharmaceuticals Quarterly |
| 2022-08-11 | 10Q | MRNS/Marinus Pharmaceuticals Quarterly |
Receive MRNS News And Ratings
See the #1 stock for the next 7 days that we like better than MRNS
MRNS Financial Statistics
Sales & Book Value
| Annual Sales: | $30.99M |
|---|---|
| Cash Flow: | $-30.88M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.86 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.66000 |
|---|---|
| Net Income (TTM): | $-149.24M |
| Gross Margin: | $29.06M |
| Return on Equity: | -1150.43% |
| Return on Assets: | -93.58% |
Marinus Pharmaceuticals Earnings Forecast
Key Marinus Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 8 years for MRNS is 93.76%.
- The Selling, General & Administrative Expenses for MRNS have been equal to 197.33% of Gross Profit Margin.
- The Research & Development expenses have been 320.72% of Revenue.
- The Interest Expense is -11.95% of Operating Income.
- The Net Earning history of MRNS is -456.31% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Marinus Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MRNS |
| CUSIP: | 56854Q |
| Website: | marinuspharma.com |
Debt
| Debt-to-Equity Ratio: | -1.2 |
|---|---|
| Current Ratio: | 2.28 |
| Quick Ratio: | 1.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MRNS Technical Analysis vs Fundamental Analysis
Sell
33
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a Sell
The current Marinus Pharmaceuticals [MRNS] share price is $0.35. The Score for MRNS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.